Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Opportunities to Optimize Cancer Policies Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Feb
18
Today In Oncology
Colorectal Cancer How Does Lifetime Alcohol Consumption Affect Risk
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Can Color Vision Deficiency Impact Survival in Bladder or Colorectal Cancer
Cancer Surgery Outcomes Similar Between Rural and Urban Facilities
Cardiovascular Effects and Risk Factors Identified With BRAF and MEK Inhibition in Melanoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo